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A B S T R A C T
Background
Better information on lung cancer occurrence in lifelong nonsmokers is needed to
understand gender and racial disparities and to examine how factors other than active
smoking influence risk in different time periods and geographic regions.
Methods and Findings
We pooled information on lung cancer incidence and/or death rates among self-reported
never-smokers from 13 large cohort studies, representing over 630,000 and 1.8 million persons
for incidence and mortality, respectively. We also abstracted population-based data for women
from 22 cancer registries and ten countries in time periods and geographic regions where few
women smoked. Our main findings were: (1) Men had higher death rates from lung cancer than
women in all age and racial groups studied; (2) male and female incidence rates were similar
when standardized across all ages 40þ y, albeit with some variation by age; (3) African
Americans and Asians living in Korea and Japan (but not in the US) had higher death rates from
lung cancer than individuals of European descent; (4) no temporal trends were seen when
comparing incidence and death rates among US women age 40–69 y during the 1930s to
contemporary populations where few women smoke, or in temporal comparisons of never-
smokers in two large American Cancer Society cohorts from 1959 to 2004; and (5) lung cancer
incidence rates were higher and more variable among women in East Asia than in other
geographic areas with low female smoking.
Conclusions
These comprehensive analyses support claims that the death rate from lung cancer among
never-smokers is higher in men than in women, and in African Americans and Asians residing in
Asia than in individuals of European descent, but contradict assertions that risk is increasing or
that women have a higher incidence rate than men. Further research is needed on the high and
variable lung cancer rates among women in Pacific Rim countries.
The Editors’ Summary of this article follows the references.
PLoS Medicine | www.plosmedicine.org September 2008 | Volume 5 | Issue 9 | e1851357
PLoSMEDICINE
Introduction
Most of the more than 1.4 million lung cancer deaths that
occur annually worldwide are caused by tobacco smoking [1].
The rest comprise only a small fraction of the total, yet they
account for a substantial disease burden. For example, in the
United States (US), factors other than cigarette smoking are
estimated to account for 10%–15% of all lung cancer deaths
[2] on the basis of surveys of smoking in the general
population and relative risk estimates from a large American
Cancer Society cohort study [2]. This percent range corre-
sponds to between 16,000 and 24,000 of the more than
161,000 lung cancer deaths projected to occur in the US in
2008 [3]. If these deaths were considered as a separate
category, they would rank among the seven to nine most
common fatal cancers in the US [4].
Not all lung cancers caused by factors other than active
smoking occur in people who have never smoked; the
background risk resulting from other exposures and their
interactions with genetic and epigenetic processes also affects
current and former smokers. However, lung cancer occur-
rence among never-smokers is of special interest for several
reasons. First, geographic and temporal variations in risk
caused by other environmental exposures and/or differences
in biological susceptibility should, in principle, be more easily
detected in populations that have never smoked. Second,
never-smokers comprise a growing proportion of adults in
economically developed countries. Whereas only 44% of US
adults (age 18 y) reported never having smoked 100 or more
cigarettes in 1965 [5], this proportion increased to 59% in
2006 [6]. Third, clinical studies have shown that lung tumors
in never-smokers have a different molecular proﬁle and
better response to targeted therapy than cancers in smokers,
and in some respects represent a different type of cancer
[7,8]. Finally, some researchers have hypothesized on the basis
of limited data that, among never-smokers, women may have
higher risk of developing lung cancer than men but lower risk
of dying from it [9,10], that age may inﬂuence the gender
relationship [11], that African Americans [4] or Asians [7] may
be at greater risk than individuals of European descent, and
that factors other than cigarette smoking may be contribu-
ting to temporal changes in lung cancer risk [12–14].
To examine these issues, we pooled data on lung cancer
incidence and death rates among self-reported never-
smokers from 13 large cohort studies representing over
630,000 and 1.8 million participants for the incidence and
mortality analyses, respectively. The studies spanned the time
period 1960 to 2004 and were based in North America,
Europe, and Asia. We supplemented the cohort analyses with
population-based incidence and death rates from lung cancer
for women in 22 cancer registries and ten countries or
geographic regions during time periods when the prevalence
of female smoking was reportedly low. All of these data are
provided in extensive supplemental tables as a resource for
other researchers (Tables S1–S23).
Methods
General Population Rates
We abstracted data on lung cancer incidence among women
from ten countries (21 cancer registries) [15] reported to have
a low prevalence of female smoking [16]. The registries were
located in India, China, and selected areas in Asia, Africa,
Europe, and the Middle East (Table 1). We selected registries
in countries where the prevalence of female smoking was
known to be low nationally or regionally in the year 2000 [16],
or where cultural or religious prohibitions discourage smok-
ing among women. We chose the time period 1983–1987 [15]
rather than more contemporary data to circumvent uncer-
tainties about recent increases in female smoking. The exact
time period differed slightly in certain countries. For
example, the incidence data for Algeria pertain to the years
1986–1989; Mali to 1987–1989; Thailand-Khon Kaen to 1988–
1989; and the Basque region of Spain to 1986–1987 [15].
We also abstracted incidence and death rates among women
in the US for the years 1935–1940 using the Connecticut
Tumor Registry for incidence [17] and US vital statistics for
mortality (Table 2) [18]. The time interval of 6 y (1935–1940)
rather than 5 y was chosen for comparability with published
data from the Connecticut Tumor Registry [17]. The lung
cancer incidence rates in Connecticut and death rates in the
US in 1935–1940 were compared to each other and to
international rates during the 1980s in other countries where
few women were known to smoke. In making temporal and
geographic comparisons we focused on the age range 40–69 y,
where the diagnosis of primary lung cancer was thought to be
less affected by changing diagnostic technologies and more
reliable than at older ages [19]. However, Tables 1 and 2
present the data over a broad range of age as a potential
resource for future studies. All age-standardized rates were
based on the IARC 2000 world population standard.
Cohort Studies
We contacted the principal investigators of large cohorts
that included a minimum of approximately 20,000 partic-
ipants who reported no history of regular tobacco smoking.
Never-smokers or lifelong nonsmokers were those who
reported never having smoked 100 cigarettes or more in their
lifetime or never having smoked any tobacco product
regularly. We excluded cohorts that were deﬁned by exposure
to speciﬁc occupational or environmental toxicants. Re-
searchers were asked to provide age-, sex-, and race-speciﬁc
data on lung cancer cases and/or deaths and person years at
risk among the lifelong nonsmokers. Mortality data were
provided for 11 studies (Table S1); incidence data for eight
(Table S2). Among the mortality studies, seven were located in
North America and Europe (the Black Women’s Health Study
[BWHS] [20], Cancer Prevention Study I [CPS-I] and II [CPS-II]
[4], the Health Professionals’ Follow-up Study [HPFS] [21], the
Multiethnic Cohort [MEC] [22], the Nurses’ Health Study
[NHS] [21], and the Women’s Health Study [WHS] [23]) and
four in Asia (Hirayama or Six Prefecture Study in Japan [24],
the Japanese Collaborative Cohort Study [JACC] [25], the
Japanese Three Prefectures Study [26], and the Korean Cancer
Prevention Study [KCPS] [27]). All of the eight studies that
provided incidence data were located in North America or
Europe (Table S2). These included BWHS, Cancer Prevention
Study II Nutrition Cohort (CPS-II Nutrition) [28], the Euro-
pean Prospective Investigation into Cancer and Nutrition
(EPIC) [29], HPFS, MEC, NHS, the Swedish Construction
Worker cohort (SCW) [30], and WHS. Only two of these
cohorts [24,30] have previously published age-speciﬁc rates in
never-smokers for the length of follow-up considered here.
We tabulated the number of events, person years at risk,
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and age-speciﬁc and age-standardized rates among never-
smokers in each contributing cohort for mortality (Tables S3–
S8) and incidence (Tables S9–S12). Most of the studies
included both men and women. The two studies of health
professionals (HPFS and NHS) were considered a paired
analysis of men and women, respectively. Two mortality
studies (WHS and BWHS) were included only in the analyses
of women. The total number of incident cases and deaths is
shown in Table 3 by gender and race.
Before pooling the data from these cohorts, we tested for
heterogeneity of the rates among the cohorts within strata of
gender and race. We ﬁrst used the likelihood ratio test in
generalized linear models (SAS GENMOD) [31] to determine
whether controlling for ‘‘study’’ improved the ﬁt of the
model, within each sex and race combination. Heterogeneity
across studies was deﬁned as a p , 0.05. Heterogeneity within
gender was observed in the mortality data for women of
European descent (p, 0.0001), Asian women (p¼0.0007), and
Asian men (p , 0.0001) and in the incidence data for women
of European descent (p ¼ 0.0015), and reached borderline
statistical signiﬁcance for men of European descent (p ¼
0.066). The two smallest studies (WHS and MEC) accounted
for the heterogeneity of the mortality rates among individuals
of European descent (both WHS and MEC) and Asians (MEC).
Their exclusion did not appreciably change the rates, since
they contributed less than 4% of deaths to any analysis. We
could not account for the higher incidence rates among
women of European descent in the CPS-II Nutrition Survey
than in the NHS.
To examine whether the age pattern for men and women
differed, we again used generalized linear models to assess
whether the age-speciﬁc rate difference changed with age.
The statistical signiﬁcance of the trend in the rate difference
(treated as linear) was tested using two-way interaction terms
between gender and age and the likelihood ratio test. Three-
way interaction terms between age, gender, and cohort were
also tested and were not signiﬁcant.
Lastly, we evaluated potential effects associated with
heterogeneity by conducting sensitivity analyses that com-
pared the rates and rate ratios from the pooled data with the
results from random effects models within strata of gender
and race where heterogeneity was detected. The results of
these two approaches were similar.
Despite some evidence of heterogeneity in both the
incidence and death rates among cohorts, we present both
pooled and cohort speciﬁc results. The pooled mortality data
are presented in Tables S13–S16 for individuals of European
descent, Asians, and African Americans, respectively; the
pooled incidence data are presented in Tables S17–S20. In
both the pooled and cohort speciﬁc analyses, the age-
standardized rates were calculated using direct standardiza-
tion to the IARC 2000 world population weights. The rates
were standardized to four different age ranges (40–69, 40–79,
40–84, and 40þ y) to facilitate comparisons with cancer
registry and national vital statistics data and with other
published results. We calculated age-speciﬁc ratios of the
male to female rates only in age strata where both sexes had
at least ﬁve events.
Two other analyses were conducted to provide additional
perspective on these risks. To compare the lung cancer risk in
never-smokers to that in smokers, we contrasted the age-
speciﬁc death rates from lung cancer among never-smokers in
the pooled data with those of current smokers in CPS-II for
individuals of European descent and KCPS for Asians (Figure
1 and Table S21). These two studies were the only contempo-
rary cohorts for which we had the relevant information on
smokers. For validity, we restricted the follow-up of the
current smokers to ﬁrst 6 y after enrollment in order to
minimize the effect of cessation, since neither CPS-II nor
KCPS collected information on changes in smoking status
during follow-up. We also calculated the cumulative proba-
bility of dying from lung cancer before age 85 y among male
and female smokers and never-smokers. The age category 80–
84 y was used as the upper limit in calculating cumulative
probability because the category age 85þwas open-ended and
undeﬁned. The other analysis compared lung cancer occur-
rence among lifelong nonsmokers in the pooled data with the
incidence and death rates for other cancers in the general
population. Population-based incidence rates were based on
the Surveillance Epidemiology and End Results (SEER) Cancer
Statistics Review for the years 2000–2004 [32]; mortality rates
were derived from US vital statistics from the same years and
source. Only the data for individuals of European descent are
presented here.
Results
International Comparisons Based on Cancer Registry Data
Table 1 presents the age-speciﬁc and age-standardized lung
cancer incidence rates among women in the 21 cancer
registries covering populations where female smoking was
thought to be uncommon. The age-standardized rates varied
by more than 30-fold even when restricted to the age range
40–69 y where the data were considered most reliable. The
lowest recorded incidence rates were among women in Africa
(Algeria and Mali) and India (Ahmedabad, Bangalore, Madras,
Mumbai). Women in the Basque region of Spain were also in
the lowest tertile ( 9 cases per 100,000) when the
comparison was restricted to the age range 40–69 y. Incidence
rates (per 100,000) in the middle tertile ranged from 11.2 in
Kuwait to 27.4 in Qidong City, China and included women in
all of the registries in Japan, the Malay population of
Singapore, the Khon Kaen registry in Thailand, and the
Qidong City registry in China. Rates in the highest tertile
ranged from 30.9 per 100,000 among women in the Rizal
Province in the Philippines to 87.8 per 100,000 in Chiang Mai,
Thailand. The variability of the rates within individual
countries was greatest in China and Thailand.
Table 1 also presents lung cancer incidence rates among
women from the Connecticut tumor registry during the years
1935–1940, a time period when few American women smoked.
The lung cancer incidence rate among Connecticut women,
ages 40–69 y was 8.5 per 100,000 in the late 1930s, similar to
that among women of the same age in the Basque region of
Spain (8.6 per 100,000) and Kuwait (11.2 per 100,000) 50 y
later. The Connecticut rates reach a plateau at age 70 y and
then decrease in the oldest age groups, consistent with under-
diagnosis of lung cancer in the elderly. The problem of under-
diagnosis in older age groups exists wherever minimally
invasive diagnostic technologies are unavailable, as would also
have been true in the US during the 1930s.
Table 2 compares the lung cancer incidence rates among
women in selected registries with national or regional
mortality rates during the same time period. With the
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exception of Hong Kong and India, the death rates shown
[33] pertain to wider geographic areas than the incidence
rates and are substantially lower, due to a combination of
regional variations in incidence and under-diagnosis of lung
cancer in areas outside of the incidence registries. The
discrepancy between the regional incidence rate and national
mortality rate is especially large in Thailand, where the
incidence among women in Chiang Mai is almost 16 times
greater than the national death rate, and even the incidence
in Khon Kaen is more than twice the national death rate. The
issue of regional variability in countries such as Thailand and
China is discussed below. Among Japanese women, the
regional incidence rates correspond well with the national
mortality data, and suggest that lung cancer risk among
women in Japan during the 1980s was in fact two to three
times higher than that of women in Kuwait or the Basque
region of Spain at that time or the incidence rate among US
women during the 1930s.
Cohort Studies of Lung Cancer Incidence and Mortality in
Never-Smokers
Study populations. As shown in Tables S1 and S2, the
cohort studies varied in size, length of follow-up, time period
covered, composition (by age, gender, and race), and nature
of the cancer endpoint (incidence and/or mortality). The 11
mortality studies are listed ﬁrst (Table S1), because they are
larger and more informative than the incidence studies.
Collectively they include 1.4 million women and nearly
440,000 men who reported never having smoked regularly.
The eight incidence studies, listed in Table S2, represent
more than 630,000 never-smokers (376,600 women and
253,600 men). The total number of lung cancer deaths among
lifelong nonsmokers is 4,795, about ﬁve times more than the
number of incident cases (958) (Table 3). This total is smaller
for Asians (1,482) and African Americans (185) than for
individuals of European descent (3,128). Most of the incident
cases are among women of European descent (511) or men of
European descent (284). Fewer than 100 incident cases have
been observed to date among Asian (69) or African American
(63) women in these cohorts, and even fewer among Asian
(22) or African American (9) men (Table 3).
The two American Cancer Society cohorts, CPS-I and CPS-
II, contributed over 90% of the mortality data for individuals
of European descent (Tables S3 and S4). The age-stand-
ardized lung cancer death rate (per 100,000 persons per year)
among women of European descent was similar in CPS-I (9.3),
CPS-II (10.6), and the NHS (10.3), but lower in the WHS (4.0)
when standardized across all ages 40 y and above (Table S3).
The death rate (per 100,000) among men of European descent
was higher in CPS-I (15.3), CPS-II (13.4), and HPFS (12.6) than
in MEC (6.4) when standardized within comparable age
ranges. CPS-I represents a time period 20–30 y earlier than
Figure 1. Age-Specific Lung Cancer Mortality Rates Comparing Current Smokers with Never-Smokers in Two Large Cohorts
Blue line indicates never-smokers; red line indicates current smokers.
doi:10.1371/journal.pmed.0050185.g001
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the other cohorts. Larger variations in the death rates were
seen between the Asian cohorts from Korea and Japan and
the MEC study of Asian Americans (Tables S5 and S6). The
age-standardized rates were about twice as high in the
massive KCPS cohort and Japanese Three Prefectures study
as in MEC. KCPS contributed approximately 90% of all lung
cancer deaths in the Asian cohorts.
Comparison of lung cancer death rates between never- and
current smokers. Figure 1 shows the age- and sex-speciﬁc lung
cancer death rates in never-smokers in the pooled data for
individuals of European descent (Table S13) and Asians
(Table S15) with the death rates among current cigarette
smokers in CPS-II for individuals of European descent and
KCPS for Asians (death rates in smokers presented in Table
S21). The rates for current smokers were based on the ﬁrst 6 y
of follow-up to minimize the effects of smoking cessation, as
noted above. Men and women of European descent who
smoked actively had lung cancer death rates that were 21.9
and 13.7 times higher, respectively, than the rates of never-
smokers, when the rates were standardized to all ages 40þ y.
When expressed as cumulative probability rather than
annual death rates, the cumulative risk of dying from lung
cancer before age 85 y was 22.1% for a male smoker and
11.9% for a female current smoker, in the absence of
competing causes of death. The corresponding estimates for
lifelong nonsmokers were a 1.1% probability of dying from
lung cancer before age 85 for a man of European descent, and
a 0.8% probability for a woman. The actual probabilities are
lower because of competing causes of death.
Mortality comparisons by gender and age. Men who
reported no history of regular smoking had higher death
rates from lung cancer than women in the pooled data for
individuals of European descent, Asians, and African Amer-
icans (Tables S13, S15, S16, respectively). The rate ratios
comparing the male and female death rates reﬂected
signiﬁcantly higher death rates in men of European descent
(rate ratio [RR]¼1.32, 95% conﬁdence interval [CI]¼1.2–1.5)
and Asian men (RR¼ 1.96, 95% CI¼ 1.4–2.7) than women, at
all ages 40þ (Tables S13 and S15, respectively). Age-speciﬁc
comparisons could not be made among African Americans
because of the small number of deaths in men (Table S16).
However, the age-standardized death rates were 20%–33%
higher in African American men than in African American
women, depending on the age range being considered. The
gender gap increased with age among individuals of European
descent and Asians. Figure 2 illustrates the divergence of the
male and female death rates among never-smokers with
increasing age in the three largest cohort mortality studies.
The gender difference was largest in KCPS for the years 1992–
2004, intermediate in CPS-I from 1959 to 1970, and smallest in
CPS-II from 1982–2004. When the pooled data were examined
by Poisson regression analyses that controlled for study, age
signiﬁcantly modiﬁed the association with gender in individ-
uals of European descent (p¼0.01) and Asians (p¼0.0004) but
not African Americans (p ¼ 0.79) (Tables S13, S15, S16,
respectively). The age-related increase in the rate ratio
estimates comparing the male and female lung cancer death
rate remained statistically signiﬁcant in analyses restricted to
cohorts or pairs of cohorts that provided data on both men
and women (p-trend¼ 0.002, Table S14).
Mortality comparisons by race. The lung cancer death rates
in the pooled analyses were highest in Asians, intermediate in
African Americans, and lowest in individuals of European
descent who reported no history of regular smoking (Figure 3
and Table 4). The rate ratio estimates compared to
individuals of European descent were statistically signiﬁcant
for Asian men (RR ¼ 1.96, 95% CI ¼ 1.7–2.3), Asian women
(RR¼ 1.69, 95% CI¼ 1.5–1.8), and African American women
(RR¼ 1.34, 95% CI¼ 1.1–1.7) when standardized to ages 40–
84 y. The rate ratio comparing African American men to men
of European descent was similar to that for women (RR ¼
1.33, 95% CI ¼ 0.9–2.1) (Table 4). It should be noted that
among the Asian cohorts (Tables S5 and S6), the age
standardized lung cancer death rates were two- to ﬁve times
lower for Japanese Americans in the MEC study than for men
and women in the cohorts from Korea (KCPS) and Japan
(Hirayama, JACC, and Three Prefectures). The lung cancer
death rates among Japanese living in California and Hawaii
were much closer to the rates of individuals of European
descent than to the rates of Asians living in Korea and Japan
(Tables S5 and S6). Age did not signiﬁcantly modify the racial
differences in risk among lifelong nonsmokers.
Mortality comparisons by time period. The only cohort
data that provided meaningful comparisons of lung cancer
risk among never-smokers in different time periods were the
two American Cancer Society cohorts CPS-I (1959–1972) and
CPS-II (1982–2004) [4,34–37]. A previous analysis based on
CPS-II follow-up from 1982–2000 found that the lung cancer
death rate in never-smokers was higher in CPS-II than in
CPS-I among women of European descent (hazard ratio [HR]
¼ 1.25, 95% CI¼ 1.12–1.41) but not men of European descent
(HR ¼ 0.89, 95% CI ¼ 0.74–1.08) [4]. The present analysis
extended CPS-II follow-up for 4 additional y and found no
statistically signiﬁcant evidence that the death rate was higher
in CPS-II than in CPS-I for women of European descent (RR¼
1.11, 95% CI ¼ 0.98–1.25), African American women (RR ¼
1.15, 95% CI¼ 0.62–2.13), or men of European descent (RR¼
0.83, 95% CI ¼ 0.66–1.05). In other analyses, we divided the
CPS-II follow-up into two segments of equal duration and
found essentially the same age-standardized death rates
among never-smokers during both periods (analyses not
shown).
Incidence rates in cohort studies. The lung cancer
incidence rates in the cohort studies were based on fewer
cases than the mortality studies and were less precise,
especially for Asians and African Americans. However, the
incidence rate among women of European descent age 40–69 y
in the pooled cohort data (Table S17) was very similar to the
general population rates among individuals of European
descent in populations with a low prevalence of female
smoking (Table 1). For example, the age-standardized in-
cidence rate among women of European descent age 40–69 y
in the cohort studies was 9.7 per 100,000 (Table S17) compared
to 8.5 per 100,000 among US women in the 1930s and 8.6 in
the Basque region of Spain during the 1980s (Table 1). At older
ages, the female death rates increased more rapidly with age in
the pooled cohort data than among women in Connecticut in
the 1930s or in the Basque region of Spain during the 1980s.
No similar comparisons could be made between incidence
rates among Asian women in the cohort studies and women in
Asian countries; the only incidence data on Asian never-
smokers came from the MEC cohort in North America.
Incidence comparisons by gender and age. The age-speciﬁc
and age-standardized rate estimates in the cohort studies
PLoS Medicine | www.plosmedicine.org September 2008 | Volume 5 | Issue 9 | e1851363
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were much less precise for incidence (Tables S9–S12) than for
mortality (Tables S3–S8), even among individuals of Euro-
pean descent. Age-speciﬁc comparisons could be made only
in this latter group. No meaningful difference was observed
between the lung cancer incidence rate in men of European
descent (14.0 per 100,000) and women (13.8 per 100,000) who
had never smoked, when the rates were standardized to all
ages 40 y and above (Table S17). However, the gender
relationship observed in the incidence data for individuals of
European descent appeared to change qualitatively with
increasing age (Figure 4). In the pooled data, women who
never smoked had higher incidence rates than men in the age
range 40–59 y; similar incidence rates between ages 60 y and
79 y; and lower incidence rates beginning at approximately
age 80 y. In only two 5-y age groups (50–54 y and 55–59 y) did
the ratio of the male to female rate achieve borderline
statistical signiﬁcance (Table S17). Furthermore, the absolute
difference between the male and female death rates was small,
even in these two age groups (absolute difference ¼ 3.9 and
4.4 cases per 100,000 at ages 50–54 y and 55–59 y,
respectively). The trend in the rate difference with age was
not statistically signiﬁcant (p ¼ 0.06) when all cohorts were
included in the pooled analysis. The evidence of a trend was
further weakened by restricting the analysis to cohorts or
pairs of cohorts that provide incidence data on both sexes (p
¼ 0.21) (Table S18).
Incidence comparisons by race and ethnicity. African
American women had signiﬁcantly higher incidence rates
from lung cancer than women of European descent who had
never smoked (RR ¼ 1.56, 95% CI ¼ 1.1– 2.1). The incidence
data available for African American men and Asian men and
women were too sparse to make meaningful comparisons. As
noted above, incidence data for Asian never-smokers derived
entirely from the MEC study in the US (Tables S11 and S12).
Figure 2. Sex- and Age-Specific Lung Cancer Death Rates in Three Large Cohorts
(A–C) Blue line indicates men; red line indicates women.
doi:10.1371/journal.pmed.0050185.g002
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Frequency of lung cancer in never-smokers versus other
cancers in population. We compared the mortality and
incidence rates from lung cancer among lifelong nonsmokers
in the pooled data for individuals of European descent with
US death rates and with SEER incidence rates from other
types of cancer in the general population (Tables S22 and
S23). The lung cancer death rate in never-smokers was
comparable to, and in some cases higher than, the death rate
from other types of cancer in the general population,
especially at older ages. For example, the death rate among
men of European descent who reported never smoking
exceeded the general population death rate for melanoma
beginning at age 50 y, from cancer of the brain and other
nervous system at ages 65þ y, from cancers of the kidney and
liver at ages 70þ y, and from cancer of the esophagus at ages
80þ y. The same was observed among women of European
descent for cancers of the uterine corpus and liver beginning
at age 35 y, for melanoma and cancer of the esophagus at ages
40þ y, for all leukemia at ages 45þ y, for uterine cervix at ages
50þ y, and for cancers of the brain and other nervous system
at ages 60þ y.
Using the lung cancer death rates in the pooled data, we
estimated the number of lung cancer deaths that would have
occurred among individuals of European descent and African
Americans in the US in 2004, if the entire population in these
two groups, age 40þ y had experienced the death rates of
lifelong nonsmokers. We limited the analysis to individuals of
European descent and African Americans, because of the lack
of reliable death rates or populations at risk for other racial
and ethnic groups. The estimated number of deaths (15,943)
comprises slightly more than one-tenth the number of lung
cancer deaths (154,202) that actually occurred among
individuals of European descent and African Americans in
2004. This exceeds the number of deaths reported in 2004
from ﬁve of the 12 most common fatal cancers in the US:
cancer of the ovary, liver and intrahepatic bile duct, urinary
bladder, esophagus, and kidney or renal pelvis.
A similar approach, using the lung cancer incidence rates
in the pooled data for never-smokers of European descent
and African American never-smokers and the populations,
age 40 y and above living in the 17 SEER areas of the US in
2004, estimated that 5,064 incident lung cancers would have
occurred if no one smoked. By this estimate, lung cancer
among never-smokers would rank 11th among the 12 most
common incident cancers in SEER areas of the US in 2004. By
comparison, 6,432 cases of leukemia, 4,737 cases of stomach
cancer, and 4,516 cases of thyroid cancer were diagnosed
among African American residents and residents of Euro-
pean descent of these SEER areas in 2004.
Discussion
To our knowledge, this is the ﬁrst comprehensive effort to
pool and compare data on lung cancer incidence and death
rates in lifelong nonsmokers from multiple sources. The
combination of data from cohort studies and population
registries provides a more coherent picture of how back-
ground lung cancer risk varies by age, sex, geographic
location, race/ethnicity, and time period than can be obtained
from any single study. All of the available data have
limitations and unknowns regarding the accuracy of the
diagnostic information, the validity and comparability of the
exposure information on active smoking or its absence, and
the lack of measurements of other exposures that affect lung
cancer risk. In the interest of clarity, however, we ﬁrst discuss
the series of questions raised in the introduction and later
consider how these data limitations could affect our
conclusions.
Figure 3. Age-Standardized Lung Cancer Death Rates by Race and Sex in
the Pooled Analyses
doi:10.1371/journal.pmed.0050185.g003
Table 4. Comparing Pooled Lung Cancer Rates (Per 100,000) among Lifelong Nonsmokers by Race
Variable Category Men Women
Age-Standardized Ratea Rate Ratiob Age-Standardized Ratea Rate Ratiob
Mortality European Descent 12.0 (10.5, 13.6) 1.00 (referent) 9.5 (8.5, 10.5) 1.00 (referent)
African American 16.0 (12.3, 19.6) 1.33 (0.9, 2.1) 12.7 (10.5, 15.0) 1.34 (1.1, 1.7)
Asian 26.0 (23.8, 28.1) 1.96 (1.7, 2.3) 16.1 (14.6, 17.5) 1.69 (1.5, 1.8)
Incidence European Descent 11.2 (9.8, 12.6) 1.00 (referent) 12.4 (11.3, 13.5) 1.00 (referent)
African American 12.3 (3.2, 21.4) 1.10 (0.5, 2.3) 19.4 (14.2, 24.6) 1.56 (1.2, 2.1)
Asian 12.9 (6.7, 19.1) 1.15 (0.7, 1.9) 15.0 (10.4, 19.7) 1.14 (0.8, 1.6)
aStandardized to the IARC World Standard Population for 2000, ages 40–84 y (95% confidence intervals).
bRate ratio in comparison to individuals of European descent.
doi:10.1371/journal.pmed.0050185.t004
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How Common Is Lung Cancer in People Who Have Never
Smoked Actively?
The incidence of lung cancer among lifelong nonsmokers
falls within the National Cancer Institute’s (NCI) deﬁnition of
a ‘‘rare’’ cancer (fewer than 40,000 cases per year, age-
standardized incidence rate ,15 per 100,000). The incidence
rate approximates that of brain cancer (plus other nervous
system cancers) in the SEER registries for individuals of
European descent under age 70 y. At older ages, the incidence
rates increase more rapidly than the incidence of brain
cancer and become comparable to the SEER incidence rates
for liver and kidney cancer.
The lung cancer incidence and death rates among never-
smokers are predictably much lower than those of smokers.
Men who report never smoking have a 1.1% cumulative risk
of dying from lung cancer before age 85 y in the pooled
analysis of individuals of European descent; the correspond-
ing estimate for women is 0.8%. This compares to cumulative
risk estimates of 22.1% and 11.9% for male and female
current cigarette smokers, respectively, during the ﬁrst 6 y of
follow-up of CPS-II. Nevertheless, the disease burden from
lung cancer would be comparable to that of many other
cancers, even if the entire population experienced the death
rates of lifelong nonsmokers. While we lack information on
the lung cancer death rates among Hispanic, Native
American, and Asian never-smokers who live in North
America, we can make such estimates for individuals of
European descent and African Americans. Our estimate that
approximately 16,000 lung cancer deaths would have
occurred among individuals of European descent and African
Americans, ages 40–79 y in 2004, had the never-smoker rates
applied, is larger than the number reported for ﬁve of the 12
most common fatal cancers in the US in that year. Lung
cancer is obviously a signiﬁcant public health and medical
problem, even beyond the overwhelming disease burden
caused by tobacco smoking.
Do Women Have Higher Risk Than Men?
The question of whether women are more susceptible to
develop lung cancer than men has been debated since the
early 1990s, when reports from case-control studies showed
Figure 4. Sex- and Age-Specific Lung Cancer Incidence Rates in Individuals of European Descent, with and without CPS-II Nutrition Cohort
(A–C) Blue line indicates men; red line indicates women.
doi:10.1371/journal.pmed.0050185.g004
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higher odds ratios in women than in men associated with
putatively comparable levels of cigarette smoking [38–40].
These reports were not replicated by large prospective
studies in the US [41] or Europe [42,43] that measured lung
cancer mortality rates. The prospective cohort studies have
consistently found higher lung cancer death rates in men
than women, both in the presence [41] and absence [4] of
active smoking. The literature is less consistent with respect
to incidence, however [44]. The debate has been further
complicated by publications from national and international
Early Lung Cancer screening studies [9,45], suggesting that
the gender relationship may be different for incidence than
for mortality. Screening studies have found that women are
more likely to be diagnosed with lung cancer than men when
high risk smokers are tested with low-dose spiral compu-
terized tomography. Although screening studies measure
disease prevalence rather than incidence, Henschke and
others hypothesize that lung cancer incidence may be higher
in women than in men who smoke, even though the opposite
is true for mortality [9]. Wakelee et al. provided limited
support for this hypothesis by documenting that lung cancer
incidence rates were higher in women than men among
never-smokers, age 40–79 y in six cohort studies [11].
Our ﬁndings are much clearer for lung cancer mortality
than for incidence. The lung cancer death rates are higher in
men than women who have never smoked, and the gender
difference in mortality increases with age. This has been
previously reported for individuals of European descent and
African Americans [4]; the addition of new data from Korea
[27] and Japan [25,26], extends this ﬁnding to Asians. The
gender difference in mortality may be narrowing over time,
as suggested by the decrease in the HR comparing the male to
female rate in CPS-I (HR¼ 1.52, 95% CI¼ 1.28–1.79) to that
in CPS-II (HR¼1.21, 95% CI¼1.09–1.36). Whether this trend
will continue into the future is unknown.
In contrast to the mortality ﬁndings, the gender relation-
ship observed for lung cancer incidence is more complex and
less convincing. We had no a priori hypothesis that age would
modify the relationship between gender and lung cancer
incidence rates; the rate was higher in women than men
before age 70 y, but lower in women than men at age 80 y and
above. Chance may explain this unexpected ﬁnding. The
incidence rate was signiﬁcantly higher in women than men in
only two age groups (50–54 y and 55–59 y). Age was
marginally signiﬁcant (p ¼ 0.06) as an effect modiﬁer when
all cohorts are included in the pooled analysis; the association
is much weaker when analyses consider only those cohorts or
pairs of cohorts that provide incidence data on both sexes (p
¼ 0.21). Biases may affect some ages more than others. The
gender-speciﬁc rates vary across cohorts, and different
studies contributed differentially to different age groups. In
any case, our analyses do not provide independent repli-
cation of the Wakelee et al. results [11], since three cohorts
(NHS, HPFS, MEC) were included in both studies.
It is nevertheless provocative that younger women have
higher lung cancer incidence rates than men among never-
smokers of European descent, and that African American and
Asian women have higher age-standardized lung cancer
incidence rates than men, even though the differences are
not statistically signiﬁcant. Relative survival is somewhat
better in women than men among all patients with lung
cancer, especially at younger ages [32]. However, unless the
gender difference in survival is considerably larger in never-
smokers than smokers with lung cancer, one would not expect
a 1-y relative survival of 41.3% in women and 38.3% in men
to account for the gender pattern in lung cancer incidence
that we observed.
Do African Americans Have Higher Risk Than Individuals
of European Descent?
The pooled cohort data strengthen the evidence that lung
cancer risk is higher in African Americans than individuals of
European descent who have never smoked. The death rate
from lung cancer was previously reported to be higher in
African American women than in women of European
descent in CPS-II [4], but with limited data for African
American men, and no information by which to compare
incidence rates in individuals of European descent and
African Americans. The pooled data in these analyses add
new information on mortality rates among African American
from BWHS, MEC, and additional follow-up of CPS-II, and
new data on lung cancer incidence from BWHS, MEC, and
the CPS-II Nutrition cohort. The lung cancer mortality rate
among African Americans who report no active smoking,
compared to that of individuals of European descent, is
higher for both women (RR¼1.34, 95% CI¼1.1–1.7) and men
(RR ¼ 1.33, 95% CI ¼ 0.9–2.1) in the age range 40–84 y.
Similarly, the incidence of lung cancer is higher in African
American women than in women of European descent who
have never smoked (RR ¼ 1.56, 95% CI ¼ 1.1–2.1); there are
too few cases among African American men to make
meaningful comparisons. These data support the hypothesis
that lung cancer incidence and death rates are higher among
African Americans than individuals of European descent,
even in the absence of active tobacco smoking, and that this
difference in baseline risk may explain part but not all of the
disparity in risk observed between African American and
smokers of European descent.
Do Asians Have Higher Lung Cancer Risk Than Individuals
of European Descent?
Lung cancer incidence rates were higher and more variable
among women in East Asia than in other geographic areas
with low prevalence of female smoking. The very high
incidence rates observed among women in the Tianjin
registry in northeastern China and the Chiang Mai registry
in northern Thailand are consistent with the large regional
variations that have been reported previously among women
in Asia, and especially in China [46–49]. Li et al. reported a
20-fold difference between the lung cancer death rate
between Chinese women living in counties at the tenth and
90th percentiles, based on a retrospective mortality survey
conducted from 1973 to 1975 [46]. Some of this variation
undoubtedly reﬂects variation in active smoking. The
prevalence of active smoking among women in China in
2003 ranged from about 4% in the southern provinces of
Hainan and Guangxi to approximately 13% in the northern
provinces of Heilongjiang and Inner Mongolia [50]. Other
factors likely to contribute to lung cancer risk among Chinese
women include indoor air pollution from coal smoke from
unventilated coal-fueled stoves [51,52], volatilization of oils
from cooking at high temperatures in open woks [53–56], and
secondhand smoke [53,57–59]. Older women in northeastern
China (Tianjin and Harbin) and northern Thailand (Chiang
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Mai and Lampang) have traditionally smoked more than
women in other parts of China and southern Thailand. Pipe
smoking was once common among older women in north-
eastern China. A local tobacco product called keeyo was
smoked historically by women in northern Thailand. It
remains unclear to what extent active smoking versus indoor
air pollution from cooking and secondhand smoke contribute
to the high rates of lung cancer and chronic obstructive lung
disease among women in northeastern China and northern
Thailand.
We did not expect that lung cancer incidence rates would
be two to three times higher among Asian women, age 40–69
y, living in the Philippines, Hong Kong, Japan, and the
Chinese population of Singapore than among Western
women of the same age in populations with low female
smoking prevalence. Other studies have reported that lung
cancer rates have decreased over successive birth cohorts
among women in Hong Kong [60] and Singapore [61]. In
these countries, the lung cancer incidence rate peaked among
women born around 1908 and decreased in later birth
cohorts. Further population-based research is needed to
characterize lung cancer incidence and death rates among
women in Paciﬁc Rim countries by birth cohort, smoking
status, and exposure to other factors that may affect risk. The
data needed must come from cohort studies and not hospital-
based case series that measure proportions rather than rates.
Several studies from Korea and other Paciﬁc Rim countries
have observed a smaller proportion of active smokers among
female lung cancer patients in Asia than in the West [62,63],
yet these are difﬁcult to interpret because they measure only
the proportion of people who are exposed to the risk factor
of interest, not the actual risk (incidence or death rates)
among smokers or never-smokers. Active smoking has been
considered uncommon among women in most Asian coun-
tries, but the relatively high lung cancer rates raise the
possibility of incomplete reporting of active smoking.
Has Lung Cancer Risk among Lifelong Nonsmokers
Changed over Time?
A challenge in interpreting temporal trends in cancer
incidence and death rates is to distinguish actual changes in
disease occurrence from artifacts due to changes in disease
detection or classiﬁcation. Technological advances such as
bronchoscopy, percutaneous thin needle biopsy, and imaging
technologies make it possible to biopsy pulmonary masses
without open chest surgery [64]. These technologies partic-
ularly affect the rates in older patients, increasing the
likelihood that primary lung cancers will be detected, and
decreasing the chances that pulmonary metastases will be
misdiagnosed as lung cancer. Thus, temporal comparisons are
most informative when restricted to the age range 40–69 y,
where the diagnostic information was more reliable, even
before the advent of these technologies. We ﬁnd no
indication that lung cancer rates have changed among
lifelong nonsmokers within this age range in the US since
the 1930s. The historical incidence rates among Connecticut
women aged 40–69 y in 1935–1940 are similar to the
incidence rates in the mid-1980s in other Western countries
where female smoking is still uncommon. Likewise, the death
rates among US women of this age in the 1930s are similar to
the contemporary death rates among never-smokers in the
pooled cohort studies. Nor have the lung cancer death rates
changed appreciably among never-smokers from CPS-I
(1959–1972) to CPS-II (1982–2004). The death rate was
slightly lower in CPS-II than in CPS-I for men of European
descent ages 40 y and above (RR¼ 0.83, 95% CI¼ 0.66–1.05)
but slightly higher for women of European-descent (RR ¼
1.11, 95% CI¼ 0.98–1.25) and African American women (RR
¼ 1.15, 95% CI ¼ 0.62–2.13). Even among never-smokers age
80 y and above, the lung cancer death rates in the two studies
appear to be converging with longer follow-up of CPS-II.
Our ﬁndings do not support assertions by Enstrom,
Axelson, and others [12–14,65,66] that lung cancer risk has
increased substantially in the United States in lifelong
nonsmokers. Most of the increase reported by Enstrom was
based on a comparison of national lung cancer mortality
rates in 1935 with the much lower death rates recorded in
1914 in a survey of deaths in 24 states conducted by the US
Census [67]. However, the 1914 survey was conducted before
the International Classiﬁcation of Diseases (ICD) was modi-
ﬁed to include respiratory cancer (1929) or cancers of the
lung and pleura (1938) [68]. Furthermore, some of the deaths
attributed to tuberculosis in the early 20th century may have
involved misdiagnosis of lung cancer. The death rate from
tuberculosis decreased by two-thirds between 1915 and 1935
[69], a period when lung cancer mortality was rising,
especially in men [70,71]. Several other studies that report-
edly found an increase in lung cancer risk among never-
smokers [13,14,65,66] relied on statistical modeling rather
than direct measurement, and failed to consider the
progressive increase in the risks associated with active
smoking as the average duration of smoking has lengthened
in the population.
Strengths and Limitations of the Analyses
A singular strength of our analysis is its ability to compare
incidence and death rates from multiple sources in well-
deﬁned populations from different countries, time periods,
and demographic subgroups. The general population or
ecological data on women cover a 70-y time span and
represent the total population—not a selected subgroup—of
a diverse range of countries or regions. The pooled cohort
data, which provide individual level information on smoking
behavior and disease endpoints, yield more stable and
statistically precise estimates of age-, sex-, and race-speciﬁc
incidence and death rates than have been available from
individual studies. The use of a common set of weights to
standardize for age allows valid comparisons of age-stand-
ardized as well as age-speciﬁc rates across all groups.
It is reassuring that the pooled incidence and death rates
for women age 40–69 y in the cohort studies are similar to
those in the general population of countries with a similar
level of economic development. It is also noteworthy that the
lung cancer incidence rates among male never-smokers in the
more afﬂuent cohorts (CPS-II and HPFS) are similar to those
in SCW. This argues against the assertion by some [13,14,65]
that the CPS-II rates underestimate the occurrence of lung
cancer among men in the general population who have never
smoked because the participants are less exposed to occupa-
tional and environmental pollutants. The incidence and
death rates in the different cohort studies are far more
remarkable for their similarities than their differences,
despite the statistical evidence of some heterogeneity.
Our analyses are limited by uncertainties about the
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accuracy and completeness of the diagnostic information, by
potential errors in the classiﬁcation of exposure, and by the
paucity of data available to examine risk in relation to race/
ethnicity (especially in African American men and Hispanics).
Diagnostic errors are especially problematic when comparing
lung cancer rates across different time periods or countries at
different stages of economic development. Missed diagnoses
almost certainly contribute to the low recorded rates of lung
cancer in Africa and parts of India during the 1980s, and to
the lower incidence and death rates recorded in the oldest
age groups. It is not clear how to quantify or minimize this
uncertainty, except by restricting comparisons to the age
range 40–69 y. Diagnostic errors are less of a concern in the
cohort studies than in the ecological data, since most of the
follow-up of these cohorts was conducted since 1980 in
industrialized countries.
Uncertainties about errors or incompleteness in the
exposure information complicate the interpretation of
regional variations in lung cancer risk among women in
China and other countries in East Asia. Even a small amount
of misclassiﬁcation of smokers among the never-smokers
could have a substantial impact on the rates. It is difﬁcult to
ﬁnd historical information on regional variations in active
smoking by women or other exposures that may affect lung
cancer risk. It is possible that smoking histories may be
reported differently in Asia than in the West, and that former
smokers or others who consumed relatively few cigarettes
over a lifetime were more likely to be classiﬁed as never-
smokers in the Korean and Japanese cohorts than studies
based in Europe or North America.
Our analyses had limited ability to examine risk in
subgroups of the population that have been historically
underrepresented in cohort studies. Both the incidence and
mortality data were especially sparse for African American
men and Hispanics. The incidence data were also limited for
Asian men and women and African American women. Even
in individuals of European descent, the incidence data were
not sufﬁciently robust to resolve whether women under age
60 y have higher lung cancer incidence rates than men, or
whether age modiﬁes the gender relationship.
Finally, we did not attempt to identify speciﬁc exposures
that may contribute to lung cancer risk in various settings.
Known risk factors include secondhand smoke, active smok-
ing of other tobacco products, and exposure to other
carcinogens such as asbestos, radon, radiation therapy,
combustion products, and various other exposures in occupa-
tional, environmental, and/or medical settings [4].
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Editors’ Summary
Background. Every year, more than 1.4 million people die from lung
cancer, a leading cause of cancer deaths worldwide. In the US alone,
more than 161,000 people will die from lung cancer this year. Like all
cancers, lung cancer occurs when cells begin to divide uncontrollably
because of changes in their genes. The main trigger for these changes in
lung cancer is exposure to the chemicals in cigarette smoke—either
directly through smoking cigarettes or indirectly through exposure to
secondhand smoke. Eighty-five to 90% of lung cancer deaths are caused
by exposure to cigarette smoke and, on average, current smokers are 15
times more likely to die from lung cancer than lifelong nonsmokers
(never smokers). Furthermore, a person’s cumulative lifetime risk of
developing lung cancer is related to how much they smoke, to how
many years they are a smoker, and—if they give up smoking—to the age
at which they stop smoking.
Why Was This Study Done? Because lung cancer is so common, even
the small fraction of lung cancer that occurs in lifelong nonsmokers
represents a large number of people. For example, about 20,000 of this
year’s US lung cancer deaths will be in never-smokers. However, very
little is known about how age, sex, or race affects the incidence (the
annual number of new cases of diseases in a population) or death rates
from lung cancer among never-smokers. A better understanding of the
patterns of lung cancer incidence and death rates among never-smokers
could provide useful information about the factors other than cigarette
smoke that increase the likelihood of not only never-smokers, but also
former smokers and current smokers developing lung cancer. In this
study, therefore, the researchers pooled and analyzed a large amount of
information about lung cancer incidence and death rates among never
smokers to examine what factors other than active smoking affect lung
cancer risk.
What Did the Researchers Do and Find? The researchers analyzed
information on lung cancer incidence and/or death rates among nearly
2.5 million self-reported never smokers (men and women) from 13 large
studies investigating the health of people in North America, Europe, and
Asia. They also analyzed similar information for women taken from
cancer registries in ten countries at times when very few women were
smokers (for example, the US in the late 1930s). The researchers’ detailed
statistical analyses reveal, for example, that lung cancer death rates in
African Americans and in Asians living in Korea and Japan (but not
among Asians living in the US) are higher than those in people of the
European continental ancestry group. They also show that men have
higher death rates from lung cancer than women irrespective of racial
group, but that women aged 40–59 years have a slightly higher
incidence of lung cancer than men of a similar age. This difference
disappears at older ages. Finally, an analysis of lung cancer incidence and
death rates at different times during the past 70 years shows no
evidence of an increase in the lung cancer burden among never smokers
over time.
What Do These Findings Mean? Although some of the findings
described above have been hinted at in previous, smaller studies, these
and other findings provide a much more accurate picture of lung cancer
incidence and death rates among never smokers. Most importantly the
underlying data used in these analyses are now freely available and
should provide an excellent resource for future studies of lung cancer in
never smokers.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050185.
 The US National Cancer Institute provides detailed information for
patients and health professionals about all aspects of lung cancer and
information on smoking and cancer (in English and Spanish)
 Links to other US-based resources dealing with lung cancer are
provided by MedlinePlus (in English and Spanish)
 Cancer Research UK provides key facts about the link between lung
cancer and smoking and information about all other aspects of lung
cancer
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